These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16909036)

  • 1. Developmental perspectives on human midbrain-derived neural stem cells.
    Schwarz J; Schwarz SC; Storch A
    Neurodegener Dis; 2006; 3(1-2):45-9. PubMed ID: 16909036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental perspectives on human midbrain-derived neural stem cells.
    Schwarz J
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S466-8. PubMed ID: 18267285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midbrain-derived neural stem cells: from basic science to therapeutic approaches.
    Storch A; Sabolek M; Milosevic J; Schwarz SC; Schwarz J
    Cell Tissue Res; 2004 Oct; 318(1):15-22. PubMed ID: 15503150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.
    Kim JH; Auerbach JM; Rodríguez-Gómez JA; Velasco I; Gavin D; Lumelsky N; Lee SH; Nguyen J; Sánchez-Pernaute R; Bankiewicz K; McKay R
    Nature; 2002 Jul; 418(6893):50-6. PubMed ID: 12077607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
    Taylor H; Minger SL
    Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restorative approaches in Parkinson's Disease: which cell type wins the race?
    Meyer AK; Maisel M; Hermann A; Stirl K; Storch A
    J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation of stem cell therapy for neurological diseases.
    Schwarz SC; Schwarz J
    Transl Res; 2010 Sep; 156(3):155-60. PubMed ID: 20801412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for a curative cell therapy in Parkinson's disease.
    Laguna Goya R; Tyers P; Barker RA
    J Neurol Sci; 2008 Feb; 265(1-2):32-42. PubMed ID: 17936303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells may reshape the prospect of Parkinson's disease therapy.
    Sonntag KC; Simantov R; Isacson O
    Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation.
    Fukuda H; Takahashi J; Watanabe K; Hayashi H; Morizane A; Koyanagi M; Sasai Y; Hashimoto N
    Stem Cells; 2006 Mar; 24(3):763-71. PubMed ID: 16223855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural stem cells and Parkinson's disease.
    Storch A; Schwarz J
    J Neurol; 2002 Oct; 249 Suppl 3():III/30-2. PubMed ID: 12522569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem-cell-based strategies for the treatment of Parkinson's disease.
    Parish CL; Arenas E
    Neurodegener Dis; 2007; 4(4):339-47. PubMed ID: 17627139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.
    Arenas E
    Ann N Y Acad Sci; 2005 May; 1049():51-66. PubMed ID: 15965107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stem cells: solution to the problem of transplants in Parkinson's disease?].
    Linazasoro G
    Neurologia; 2003 Mar; 18(2):74-100. PubMed ID: 12610757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
    Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
    Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes.
    Wagner J; Akerud P; Castro DS; Holm PC; Canals JM; Snyder EY; Perlmann T; Arenas E
    Nat Biotechnol; 1999 Jul; 17(7):653-9. PubMed ID: 10404157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotrophin mRNA is highly expressed in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cell-derived nestin-positive cells.
    Jung CG; Hida H; Nakahira K; Ikenaka K; Kim HJ; Nishino H
    FASEB J; 2004 Aug; 18(11):1237-9. PubMed ID: 15180956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
    Cooper O; Parmar M; Isacson O
    Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic properties and function after grafting of attached neural precursor cultures.
    Timmer M; Grosskreutz J; Schlesinger F; Krampfl K; Wesemann M; Just L; Bufler J; Grothe C
    Neurobiol Dis; 2006 Mar; 21(3):587-606. PubMed ID: 16256357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.